Stéphanie Clisant

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Olivier Mir, Thomas Brodowicz, Antoîne Italiano et al. · The Lancet Oncology · 2016 · 279 citations

Medicine, Oncology, Pharmacology +7

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

Isabelle Laure Ray-Coquard, Julien Dômont, Emmanuelle Tresch‐Bruneel et al. · Journal of Clinical Oncology · 2015 · 191 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)

Isabelle Ray‐Coquard, Antoîne Italiano, Emmanuelle Bompas et al. · The Oncologist · 2012 · 190 citations · Full text

Medicine, Oncology, Pharmacology +15

Anthracyclines, Mitoxantrone, Radiotherapy, and Granulocyte Colony-Stimulating Factor: Risk Factors for Leukemia and Myelodysplastic Syndrome After Breast Cancer

Marie‐Cécile Le Deley, Florence Suzan, B. Cutuli et al. · Journal of Clinical Oncology · 2006 · 148 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

Antoine Adenis, Christelle de la Fouchardière, Bernard Paule et al. · BMC Cancer · 2016 · 128 citations · Full text

Medicine, Oncology, Pharmacotherapy +16